Inactivation of factor VIIa by antithrombin In Vitro, Ex Vivo and In Vivo: Role of tissue factor and endothelial cell protein C receptor

20Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Recent studies have suggested that antithrombin (AT) could act as a significant physiologic regulator of FVIIa. However, in vitro studies showed that AT could inhibit FVIIa effectively only when it was bound to tissue factor (TF). Circulating blood is known to contain only traces of TF, at best. FVIIa also binds endothelial cell protein C receptor (EPCR), but the role of EPCR on FVIIa inactivation by AT is unknown. The present study was designed to investigate the role of TF and EPCR in inactivation of FVIIa by AT in vivo. Low human TF mice (low TF, ∼1% expression of the mouse TF level) and high human TF mice (HTF, ∼100% of the mouse TF level) were injected with human rFVIIa (120 μg kg-1 body weight) via the tail vein. At varying time intervals following rFVIIa administration, blood was collected to measure FVIIa-AT complex and rFVIIa antigen levels in the plasma. Despite the large difference in TF expression in the mice, HTF mice generated only 40-50% more of FVIIa-AT complex as compared to low TF mice. Increasing the concentration of TF in vivo in HTF mice by LPS injection increased the levels of FVIIa-AT complexes by about 25%. No significant differences were found in FVIIa-AT levels among wild-type, EPCR-deficient, and EPCR-overexpressing mice. The levels of FVIIa-AT complex formed in vitro and ex vivo were much lower than that was found in vivo. In summary, our results suggest that traces of TF that may be present in circulating blood or extravascular TF that is transiently exposed during normal vessel damage contributes to inactivation of FVIIa by AT in circulation. However, TF's role in AT inactivation of FVIIa appears to be minor and other factor(s) present in plasma, on blood cells or vascular endothelium may play a predominant role in this process. © 2014 Vatsyayan et al.

References Powered by Scopus

Blood-borne tissue factor: Another view of thrombosis

942Citations
N/AReaders
Get full text

Role of tissue factor in hemostasis, thrombosis, and vascular development

566Citations
N/AReaders
Get full text

The tissue factor pathway: How it has become a 'prima ballerina'

432Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Protein C system defects inflicted by the malaria parasite protein PfEMP1 can be overcome by a soluble EPCR variant

44Citations
N/AReaders
Get full text

Antithrombin and its role in host defense and inflammation

30Citations
N/AReaders
Get full text

Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: A cohort study

26Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Vatsyayan, R., Kothari, H., Mackman, N., Pendurthi, U. R., & Rao, L. V. M. (2014). Inactivation of factor VIIa by antithrombin In Vitro, Ex Vivo and In Vivo: Role of tissue factor and endothelial cell protein C receptor. PLoS ONE, 9(8). https://doi.org/10.1371/journal.pone.0103505

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

57%

Researcher 2

29%

Lecturer / Post doc 1

14%

Readers' Discipline

Tooltip

Medicine and Dentistry 7

70%

Agricultural and Biological Sciences 1

10%

Biochemistry, Genetics and Molecular Bi... 1

10%

Business, Management and Accounting 1

10%

Save time finding and organizing research with Mendeley

Sign up for free